GENETIC ANALYSIS OF MYCOLIC ACID SYNTHESIS
GENETIC ANALYSIS OF MYCOLIC ACID SYNTHESIS
批准号:
6235352
负责人:
John T Belisle
金额:
$12.66万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 1998-07-31
关键词:
Escherichia coli Mycobacterium smegmatis antitubercular agents bacterial genetics chemical condensation cyclopropanes drug design /synthesis /production fatty acid biosynthesis gas chromatography gas chromatography mass spectrometry gene deletion mutation gene expression high performance liquid chromatography hydroxy fatty acid methylation molecular cloning nucleic acid sequence protein sequence protein structure function recombinant DNA saturated fatty acids
中文摘要
分枝杆菌细胞壁的独特结构是由于这一新颖的
共价结合的真菌酸的排列及其性质
阿拉伯半乳糖-肽多聚糖复合体。毫无疑问,生物合成的
这种细胞壁基质的生物合成途径将高度涉及
特殊的酶和酶复合体可被开发用于
抗分枝杆菌新药的开发。发展的迫切需要
控制结核病的新的和更有效的化疗药物已经
导致我们目前在定义关键细胞壁的生物合成方面所做的努力
产品。合理药物设计最有特色的目标之一
抗结核和非典型分枝杆菌病是细胞壁
霉酚酸酯-α-烷基,β-羟基长链(C80)脂肪酸。这个
对它们的生物合成的研究,可能涉及到特殊的伸长,
Claisen冷凝和“运输机”(项目1)将得到补充
通过基因鉴定、同源突变体的产生和提供
用于合成孔径雷达研究的重组酶。根据我们的主要观察,
初级真菌转移酶是众所周知的抗原85,α-抗原。
因此,编码关键靶标的基因是已知的,并且已经成熟
构建“基因敲除”突变体。Fas-I和Fas-I最近的可用性
-II酶,允许它们的基因通过反向遗传学和
也是被操纵的。已经重组的结核分枝杆菌已经被
在耻垢分枝杆菌中的表达为基因定义提供了一种现成的手段
F是结核杆菌最具特征的表型,也是
有效药物的所在地,在我们的工业合作伙伴眼中,
新药开发的首要重点。
英文摘要
The unique architecture of the mycobacterial cell wall is due to the novel
arrangement of the covalently bound mycolic acids and the characteristic
arabinogalactan-peptidoglycan complex. Undoubtedly, the biosynthetic
pathways for the biosynthesis of this cell wall matrix will involve highly
specialized enzymes and enzyme complexes that may be exploited for the
development of new anti-mycobacterial drugs. The urgent need to develop
new and more effective chemotherapeutic agents to control tuberculosis has
lead to our current endeavors in defining the biosynthesis of key cell wall
products. Among the most distinctive targets for rational drug design
against tuberculosis and atypical mycobacterioses are the cell wall
mycolates - alpha-alkyl, beta-hydroxy long chain (C80) fatty acids. The
study of their biosynthesis, presumably involving specialized elongation,
Claisen condensation and "transporters; (Project 1), will be complemented
by identification of genes, generation of isogeneic mutants, and provision
of recombinant enzymes for SAR studies. With our key observation that a
primary mycolyltransferase is the well known antigen 85, alpha-antigen
complex, the genes encoding a key target are thus known and are ripe for
construction of "knock-out" mutants. The recent availability of FAS-I and
-II enzymes, allows for their genes to be located by reverse genetics and
also manipulated. Already recombinant M. tuberculosis mycolates have been
expressed in M. smegmatis providing a ready means for genetic definition
f the most characteristic phenotype of the tubercle bacillus, and also the
site of effective drugs, and, in the eyes of our industrial partners, a
prime focus for new drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
-
批准号:10197000
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2020
-
负责人:John T Belisle
-
依托单位:
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
-
批准号:10418673
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2020
-
负责人:John T Belisle
-
依托单位:
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
-
批准号:9981167
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2020
-
负责人:John T Belisle
-
依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
-
批准号:10409724
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:10674122
-
项目类别:
-
资助金额:$17.79万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:10430146
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:9978702
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
-
批准号:10199751
-
项目类别:
-
资助金额:$75.34万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
-
批准号:10674095
-
项目类别:
-
资助金额:$43.87万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:10651645
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
-
批准号:10626133
-
项目类别:
-
资助金额:$75.14万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:10203791
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
Biology and Biosignatures of Anti-Tuberculosis Treatment Response
-
批准号:9220717
-
项目类别:
-
资助金额:$58.53万
-
财政年份:2015
-
负责人:John T Belisle
-
依托单位:
Biology and Biosignatures of Anti-Tuberculosis Treatment Response
-
批准号:8997444
-
项目类别:
-
资助金额:$61.99万
-
财政年份:2015
-
负责人:John T Belisle
-
依托单位:
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease
-
批准号:8841454
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:John T Belisle
-
依托单位:
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease
-
批准号:8301968
-
项目类别:
-
资助金额:$21.62万
-
财政年份:2012
-
负责人:John T Belisle
-
依托单位:
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease
-
批准号:8471053
-
项目类别:
-
资助金额:$20.42万
-
财政年份:2012
-
负责人:John T Belisle
-
依托单位:
7th International Conference on Tularemia 2012
-
批准号:8319962
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2012
-
负责人:John T Belisle
-
依托单位:
Regulation of lipid biosynthesis in Mycobacterium tuberculosis
-
批准号:8094156
-
项目类别:
-
资助金额:$18.51万
-
财政年份:2011
-
负责人:John T Belisle
-
依托单位:
Administrative Core
-
批准号:8261436
-
项目类别:
-
资助金额:$50.46万
-
财政年份:2011
-
负责人:John T Belisle
-
依托单位:
海外基金